DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Fipamezole is an investigational drug.
There have been 4 clinical trials for Fipamezole. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2008.
The most common disease conditions in clinical trials are Parkinson Disease, Shy-Drager Syndrome, and Multiple System Atrophy. The leading clinical trial sponsors are Valeant Pharmaceuticals International, Inc., Juvantia Pharma Ltd, and Santhera Pharmaceuticals.
Recent Clinical Trials for Fipamezole
|A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Disease||Valeant Pharmaceuticals International, Inc.||Phase 1/Phase 2|
|A Study of Safety and Tolerability of Fipamezole in Adult Subjects With Parkinson's Disease Who Are Receiving Levodopa||Valeant Pharmaceuticals International, Inc.||Phase 1|
|Fipamezole in Neurogenic Orthostatic Hypotension||Santhera Pharmaceuticals||Phase 2|